← Back
$ACRS All transactions

Aclaris Therapeutics, Inc.

M

$ Value

$0

Shares

9,467

Price

$0

Filed

May 5

Insider

Name

Walker Neal

Title

CEO

CIK

0001604457

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-01

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. | The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4. | The shares vest in equal monthly installments over 15 months beginning March 1, 2024, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as the Interim CEO to the Company as of each such vesting date, provided that in the event he ceases to be Interim CEO but continues to provide Continuous Service in any capacity, such awards will continue to vest in the event that the Issuer's Board of Directors determines in its sole discretion that he achieved the Performance Goals (as defined in his letter agreement of employment as Interim CEO) prior to the cessation of his employment as Interim CEO.

Filing Info

Accession No.

0001415889-25-011955

Form Type

4

Issuer CIK

0001557746

Walker Neal's History

Date Ticker Type Value
2026-02-03 ACRS M
2026-02-03 ACRS F $65K
2026-02-03 ACRS M $0
2026-02-02 ACRS A $0
2026-02-02 ACRS A $0
2026-01-02 ACRS M
2026-01-02 ACRS F $29K
2026-01-02 ACRS M $0
2025-06-10 ALDX A $0
2025-06-10 ALDX A $0

Other Insiders at ACRS (90d)

Insider Bought Sold Last
Walker Neal
CEO
2026-02-03
Loerop James
Chief Business Officer
2026-02-03
Balthaser Kevin
Chief Financial Officer
2026-02-03
Davis Hugh M.
President and COO
2026-02-03
Hall Jesse Wayne
Chief Medical Officer
2026-02-02
Kolbeck Roland Wilhelm
Chief Scientific Officer
2026-02-02